• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增生性玻璃体视网膜病变患者玻璃体液和视网膜下液细胞中的生长因子

Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.

作者信息

Baudouin C, Fredj-Reygrobellet D, Brignole F, Nègre F, Lapalus P, Gastaud P

机构信息

Department of Ophthalmology, School of Medicine, Nice, France.

出版信息

Ophthalmic Res. 1993;25(1):52-9. doi: 10.1159/000267221.

DOI:10.1159/000267221
PMID:8446368
Abstract

Mechanisms accounting for the development of proliferative vitreoretinopathy (PVR) in patients with rhegmatogenous retinal detachment remain poorly understood. In a previous study, we found the presence of various growth factors in preretinal membranes that were surgically removed from patients with PVR. The present immunohistological study was undertaken in intravitreal and subretinal fluid cells from patients suffering from PVR in various stages of development, in order to seek the presence of 4 growth-promoting factors for retinal pigment epithelial cells: acidic fibroblast growth factor (FGF), epidermal growth factor (EGF), insulin-like growth factor type I (IGF-I) and transforming growth factor-beta (TGF-beta). Results were quite similar in vitreous and subretinal fluid. Acidic FGF was found in all vitreous and subretinal specimens, in 30-100% of the examined cells. Immunoreactivity for EGF could be found in 53% of intravitreal cells and 69% of subretinal fluid cells. Positive cells were seen in all vitreous specimens and in all but 1 of the subretinal fluid specimens. IGF-I-containing cells were present in 13 of 15 vitreous specimens and in 18 of 20 subretinal fluid samples (mean percentages of reactivity in positive specimens 70% and 78%, respectively). In contrast, TGF-beta 1 reactivity was found in only 8 of 15 vitreous specimens and in 11 of 20 subretinal samples. Mean percentages of reactive cells were 30% and 50%, respectively. These results suggest that several growth factors could be involved in the proliferation and migration of retinal pigment epithelial cells during the course of PVR.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

孔源性视网膜脱离患者发生增殖性玻璃体视网膜病变(PVR)的机制仍未被充分了解。在之前的一项研究中,我们发现从PVR患者手术切除的视网膜前膜中存在多种生长因子。本免疫组织学研究对处于不同发展阶段的PVR患者的玻璃体细胞和视网膜下液细胞进行检测,以寻找视网膜色素上皮细胞的4种促生长因子:酸性成纤维细胞生长因子(FGF)、表皮生长因子(EGF)、胰岛素样生长因子I(IGF-I)和转化生长因子-β(TGF-β)。玻璃体细胞和视网膜下液细胞的检测结果非常相似。在所有玻璃体细胞和视网膜下标本中,30%-100%的被检测细胞中发现了酸性FGF。53%的玻璃体细胞和69%的视网膜下液细胞可检测到EGF免疫反应性。在所有玻璃体标本以及除1份外的所有视网膜下液标本中均可见阳性细胞。15份玻璃体标本中的13份以及20份视网膜下液样本中的18份存在含IGF-I的细胞(阳性标本中的平均反应百分比分别为70%和78%)。相比之下,仅在15份玻璃体标本中的8份以及20份视网膜下样本中的11份发现了TGF-β1反应性。反应性细胞的平均百分比分别为30%和50%。这些结果表明,在PVR病程中,几种生长因子可能参与了视网膜色素上皮细胞的增殖和迁移。(摘要截选至250词)

相似文献

1
Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.增生性玻璃体视网膜病变患者玻璃体液和视网膜下液细胞中的生长因子
Ophthalmic Res. 1993;25(1):52-9. doi: 10.1159/000267221.
2
Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.增殖性玻璃体视网膜病变中视网膜色素上皮细胞的转铁蛋白受体表达
Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2822-9.
3
Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy.增殖性玻璃体视网膜病变患者玻璃体液和视网膜下液中细胞成分的免疫细胞学研究
Ophthalmologica. 1991;203(1):38-46. doi: 10.1159/000310223.
4
Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy.糖尿病视网膜病变和增殖性玻璃体视网膜病变患者视网膜前膜中的酸性成纤维细胞生长因子及其他生长因子。
Ophthalmic Res. 1991;23(3):154-61. doi: 10.1159/000267115.
5
Quantitative assessment of growth stimulating activity of the vitreous during PVR.增殖性玻璃体视网膜病变(PVR)期间玻璃体生长刺激活性的定量评估
Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2436-42.
6
[Immunomorphological study of the vitreous body and subretinal fluid in vitreoretinal proliferation].[玻璃体视网膜增殖中玻璃体和视网膜下液的免疫形态学研究]
J Fr Ophtalmol. 1991;14(3):147-52.
7
Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy.增殖性玻璃体视网膜病变中玻璃体和视网膜下液细胞成分的II类组织相容性抗原表达
Invest Ophthalmol Vis Sci. 1991 Jun;32(7):2065-72.
8
Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.增殖性玻璃体视网膜病变发生前血管内皮生长因子与色素上皮生长因子的平衡
Ophthalmic Res. 2007;39(3):148-54. doi: 10.1159/000103234. Epub 2007 May 25.
9
Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.病理性玻璃体可使细胞系来源(而非供体来源)的视网膜色素上皮细胞在培养中呈现增殖性玻璃体视网膜病变样特征。
Clin Exp Ophthalmol. 2014 Nov;42(8):745-60. doi: 10.1111/ceo.12307. Epub 2014 Jun 23.
10
Expression of growth factor mRNA in rabbit PVR model systems.生长因子mRNA在兔增殖性玻璃体视网膜病变模型系统中的表达
Curr Eye Res. 1992 Nov;11(11):1031-9. doi: 10.3109/02713689209015074.

引用本文的文献

1
Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases.基于纳米技术的眼部给药系统:眼部疾病治疗的综合综述
Discov Nano. 2025 May 3;20(1):75. doi: 10.1186/s11671-025-04234-6.
2
Role of HDAC3 in the epithelial-mesenchymal transition of retinal pigment epithelium cells: Implications for proliferative vitreoretinopathy.组蛋白去乙酰化酶3在视网膜色素上皮细胞上皮-间质转化中的作用:对增殖性玻璃体视网膜病变的影响
Heliyon. 2024 Oct 11;10(21):e39333. doi: 10.1016/j.heliyon.2024.e39333. eCollection 2024 Nov 15.
3
Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell EGFR/AKT signaling pathway.
表皮生长因子受体(EGFR)的抑制减弱了表皮生长因子(EGF)诱导的视网膜色素上皮细胞EGFR/AKT信号通路的激活。
Int J Ophthalmol. 2024 Jun 18;17(6):1018-1027. doi: 10.18240/ijo.2024.06.05. eCollection 2024.
4
Vitreous function and intervention of it with vitrectomy and other modalities.玻璃体的功能以及通过玻璃体切除术和其他方式对其进行的干预。
Int J Ophthalmol. 2022 Jun 18;15(6):857-867. doi: 10.18240/ijo.2022.06.02. eCollection 2022.
5
Vitreous function and intervention of it with vitrectomy and other modalities.玻璃体功能及其通过玻璃体切除术和其他方式进行的干预。
Int J Ophthalmol. 2021 Oct 18;14(10):1610-1618. doi: 10.18240/ijo.2021.10.20. eCollection 2021.
6
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.沙利霉素抑制小鼠模型中增生性玻璃体视网膜病变的形成。
PLoS One. 2020 Dec 21;15(12):e0243626. doi: 10.1371/journal.pone.0243626. eCollection 2020.
7
[Proliferative vitreoretinopathy process-To heal or not to heal].[增殖性玻璃体视网膜病变进程——愈合与否]
Ophthalmologe. 2021 Jan;118(1):10-17. doi: 10.1007/s00347-020-01294-0.
8
miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1.微小RNA-194通过直接靶向锌指E盒结合蛋白1抑制视网膜色素上皮细胞的上皮-间质转化。
Ann Transl Med. 2019 Dec;7(23):751. doi: 10.21037/atm.2019.11.90.
9
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.聚醚离子载体盐霉素通过靶向多个细胞通路来阻断增生性玻璃体视网膜病变的病理过程。
PLoS One. 2019 Sep 17;14(9):e0222596. doi: 10.1371/journal.pone.0222596. eCollection 2019.
10
The matricellular protein CCN5 inhibits fibrotic deformation of retinal pigment epithelium.细胞基质蛋白 CCN5 抑制视网膜色素上皮的纤维化变形。
PLoS One. 2018 Dec 20;13(12):e0208897. doi: 10.1371/journal.pone.0208897. eCollection 2018.